Structures by: Toyama M.
Total: 6
Carbocyclic nucleoside
C14H17ClN4O3
RSC Medicinal Chemistry (2020)
a=8.6168(4)Å b=6.7974(3)Å c=13.2395(5)Å
α=90° β=99.344(4)° γ=90°
C47H41N5O4Zn
C47H41N5O4Zn
Dalton transactions (Cambridge, England : 2003) (2012) 41, 46 14035-14037
a=25.194(8)Å b=7.483(3)Å c=22.121(8)Å
α=90.0000° β=112.754(4)° γ=90.0000°
C72H60N6O8Zn
C72H60N6O8Zn
Dalton transactions (Cambridge, England : 2003) (2012) 41, 46 14035-14037
a=21.652(3)Å b=11.8115(16)Å c=22.608(3)Å
α=90.0000° β=93.7316(15)° γ=90.0000°
C19H33AgNS4,BF4
C19H33AgNS4,BF4
Dalton transactions (Cambridge, England : 2003) (2016) 45, 31 12548-12558
a=12.9763(18)Å b=13.0824(18)Å c=15.111(2)Å
α=90° β=94.566(2)° γ=90°
C25H37AgNS4,BF4
C25H37AgNS4,BF4
Dalton transactions (Cambridge, England : 2003) (2016) 45, 31 12548-12558
a=8.7519(5)Å b=10.4885(5)Å c=16.6546(8)Å
α=74.344(4)° β=88.806(4)° γ=81.965(4)°
C19.5H16.5Cl1.5N2O4
C19.5H16.5Cl1.5N2O4
ACS medicinal chemistry letters (2014) 5, 3 259-263
a=10.5477(9)Å b=14.464(2)Å c=14.486(2)Å
α=62.635(15)° β=70.780(10)° γ=86.674(9)°